It’s been estimated that about 400 million people worldwide have had long COVID. Some researchers say that number is much ...

A widely available antiviral medication offers new possibilities for long Covid patients seeking relief from debilitating ...

Here are three dividend stocks that retirees can buy with confidence as they offer recurring, dependable payouts and a degree ...

Two-thirds of people with post-COVID-19 syndrome have persistent, objective symptoms – including reduced physical exercise capacity and reduced cognitive test performances – for a year or more, with ...

Recent studies suggest that women and patients with multiple COVID-19 infections are at a higher risk of developing long COVID. Here are four other studies.

Paxlovid use was associated with lower rates of hospitalization and death, particularly among older adults, a new study finds ...

Long COVID remains a major health challenge for millions of people, with symptoms like brain fog lingering for months after ...

Paxlovid may offer marginal benefits for low-risk children with COVID-19; however, among high-risk children with COVID-19, Paxlovid is a safe oral option.

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

The support is designed to speed development of well-matched H5N1 vaccines and pave the way for vaccines against other ...

In this study, the authors estimated that Paxlovid reduced the risk of hospitalization by 39% (95% confidence interval [CI], 36% to 41%), with an absolute risk reduction of 0.9 percentage points. The ...

Bills in the Maryland Legislature were introduced to expand the authority of a board that could cap prescription medication ...